The Medawar Prize, named after Society co-founder Sir Peter Medawar,is recognized as the world's highest dedicated award for the most outstanding contributions in the field of transplantation. The Medawar Prize has been awarded to two or more recipients at each of our Society's biennial Congresses since 1990.
The award is made possible by a continuing generous grant from Novartis Pharma AG who agreed with the recommendations of Society Presidents Tony Monaco and Pekka Hayry that a prestigious prize be established and maintained to recognize the outstanding investigators whose contributions have had a such a profound influence on the field of organ transplantation. The Medawar Prize is universally considered to be commensurate with the most outstanding world prizes for scientific achievement.
